Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Mantle-Cell 5Glioblastoma 5Lymphoma, Non-Hodgkin 4Astrocytoma 4Oligodendroglioma 3Multiple Myeloma 3Gliosarcoma 3Central Nervous System Neoplasms 3Brain Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Large-Cell, Immunoblastic 2Hodgkin Disease 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Glioma 1Ependymoma 1

Interventions

Cyclophosphamide 5Vincristine 4Doxorubicin 3fludarabine phosphate 2Psychiatric Rehabilitation 2Prednisone 2Prednisolone 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Flow Cytometry 2Etoposide 2Cytarabine 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2sargramostim 1ruxolitinib 1nelarabine 1motesanib diphosphate 1carbendazim 1Transplantation 1Therapeutics 1Steroids 1Sensitivity and Specificity 1S-1,2-dichlorovinyl-N-acetylcysteine 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Carmustine × Clear all
NCT00669812 2013-08-26

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡